BIOISIM

Owners

Goods & Services

Software as a service (SAAS) services featuring software for modeling and the conducting of simulations of properties of drugs or chemicals including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a service (SAAS) services featuring software that allows for the prediction of drug-to-drug interactions; Software as a service (SAAS) services featuring software for the prediction of drug effects on animals and virtual patient populations; Software as a service (SAAS) services featuring software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to predict pharmacodynamic changes due to changes in routes of administration, dose, dosage form, and dosing regimen of a drug or chemical; Software as a service (SAAS) services featuring software which allow for the prediction of absorption and systemic distribution/elimination for large molecules; Software as a service (SAAS) services featuring software that incorporates artificial intelligence and machine learning to predict the clinical efficacy of new drugs before human trials and accelerate pharmaceutical drug development and FDA approval